{"id":"W2010881838","doi":"10.3899/jrheum.090128","title":"Comparative Overview of Safety of the Biologics in Rheumatoid Arthritis","year":2009,"lang":"en","type":"review","venue":"Journal of Rheumatology Supplement","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nexus Clinical Research (Canada)","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Etanercept; Adalimumab; Rituximab; Infliximab; Biologic Agents; Anakinra; Lymphoma; Oncology; Internal medicine; Intensive care medicine; Immunology; Dermatology; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016816,0.0008303124,0.002542645,0.004092751,0.0002831066,0.0009564238,0.0009603881,0.001115051,0.003550596],"category_scores_gemma":[0.002139996,0.000370439,0.00106142,0.004234102,0.0003045366,0.0009488753,0.0004343263,0.000787107,0.001051166],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001043353,"about_ca_system_score_gemma":0.001691263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002808187,"about_ca_topic_score_gemma":0.004901086,"domain_scores_codex":[0.9991528,0.0001995655,0.0001961258,0.00009700479,0.0003199066,0.00003449717],"domain_scores_gemma":[0.9985287,0.0008175937,0.000254642,0.00002682858,0.000330691,0.00004160387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002518881,0.00005565148,0.0002866684,0.07267529,0.0003834909,0.0002015457,0.00006918346,0.0002143816,0.001199253,0.001156473,0.01223919,0.9112672],"study_design_scores_gemma":[0.0001668977,0.0007759536,0.005531298,0.04788623,0.001978253,0.003029594,0.000187217,0.000169694,0.001423084,0.00160439,0.9371977,0.00004977124],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001042697,0.9993167,0.00002974381,0.00005493717,0.00003351035,0.000004048644,0.00001608635,0.000001747807,0.0004389255],"genre_scores_gemma":[0.0008729117,0.9986641,0.0001255638,0.0000734393,0.00005456442,0.000005807375,0.00002980935,7.924295e-7,0.000172939],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004092751,"threshold_uncertainty_score":0.01187789,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0760866512222513,"score_gpt":0.383231549595562,"score_spread":0.3071448983733107,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}